Navigation Links
Onyx Pharmaceuticals Announces Second Quarter 2011 Financial Results Teleconference and Webcast
Date:7/26/2011

SOUTH SAN FRANCISCO, Calif., July 26, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to discuss second quarter 2011 financial results, as well as provide a general business overview on Wednesday, August 3, 2011, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).  Financial results for the second quarter ended June 30, 2011 will be released earlier that day.

Interested parties may access a live webcast of the presentation on the company's website at:
http://www.onyx-pharm.com/investors/event-calendar

or by dialing 847-585-4405 and using the passcode 30130102#.  A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 30130102# approximately one hour after the teleconference concludes.  The replay will be available through August 17, 2011.

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx-pharm.com.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... PUNE, India , May 30, 2016 ... new market research report "Healthcare Biometrics Market ... Behavioral (Signature, Voice)), Multifactor, Multimodal), Application (Workforce ... Global Forecast to 2021", published by MarketsandMarkets, ... 2,848.3 Million by 2021 from USD 1,182.6 ...
(Date:5/30/2016)... May 30, 2016 - DCGI grants limited ... to Buerger,s disease - Stempeucel® becomes 5th off-the-shelf Stem ... the world - Buerger,s Disease (also known as Thromboangiitis ... and Globally - Prevalence of Buerger,s Disease ... and 2 per 10,000 persons in the European Community & ...
(Date:5/27/2016)... 2016 LabStyle Innovations Corp . ... Tool, today announced that the Company,s Chief Financial Officer, ... being held June 1-2 in New York, NY ... 7-9 in Los Angeles, CA. ... and operational milestones, including the U.S. FDA Clearance and commercial ...
Breaking Medicine Technology:
(Date:5/31/2016)... , ... May 31, 2016 , ... ... Solutions , today announced it has been included by Gartner, Inc. in the ... a wide range of Contact Center Infrastructure technologies, some of which include: ...
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop first demonstrated ... was something that contractors should have at their disposal on a daily basis. ... CertainTeed’s Director of Contractor Programs. , As a result, Metloop and CertainTeed ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean ... laboratories as well. However, laboratories have different challenges compared to manufacturing environments. , ... in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . This ...
(Date:5/31/2016)... ... , ... Spectrum Aquatics has launched a brand new ADA pool lift, the ... the user in mind. , “Over the last two years our key customers and ... lbs lift is a necessary requirement for certain facilities with specific needs,” said Nabil ...
(Date:5/31/2016)... ... 2016 , ... In a recent interview on The Greenburgh Report radio show ... WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross discussed several ... money maelstrom.” , During the interview with Mr. Feiner that aired on May ...
Breaking Medicine News(10 mins):